BRFAA - Biomedical Research Foundation Academy Of Athens
Biomedical Research Foundation Academy Of AthensAcademy Of Athens


Charonis AS and Wissig SL (1983). Anionic sites in basement membranes. Differences in their electrostatic properties in continuous and fenestrated capillaries. Microvasc. Res. 25, 265-285

Charonis AS, Tsilibary EC, Kramer RH and Wissig SL (1983). Presence of heparan sulfate core protein in the basement membrane of continuous capillaries and skeletal muscle cells. Microvasc. Res. 26, 108-115

Charonis AS, Tsilibary EC, Yurchenco PD and Furthmayr H (1985). Binding of laminin to type IV collagen. A morphological study. J.Cell Biol. 100, 1848-1853

Yurchenco PD, Tsilibary EC, Charonis AS and Furthmayr H (1985). Laminin polymerization in vitro. Evidence for a two-step assembly with domain specificity. J.Biol.Chem, 260, 7636-7644

Charonis AS, Tsilibary EC, Saku T and Furthmayr H (1986). Involvement of the globule of the long arm of laminin in its polymerization and binding to type IV collagen. J.Cell Biol. 103, 1689-1697

Tsilibary EC and Charonis AS (1986). The role of the main non-collagenous NC1 domain in type IV collagen self-assembly. J.Cell Biol. 103, 2467-2473

Yurchenco PD, Tsilibary EC, Charonis AS and Furthmayr H (1986). Models for the self-assembly of basement membrane. J.Histochem.Cytochem. 34, 93-102

Skubitz APN, Charonis AS, Tsilibary EC and Furcth LT (1987). Localization of a tumor cell adhesion domain of laminin by a monoclonal antibody. Exp. Cell Res. 173, 349-360

Tsilibary EC, Charonis AS, Reger L, Wohlhueter R and Furcht LT (1988). The effect of non-enzymatic glycosylation on the binding of the main non-collagenous NC1 domain to type IV collagen. J.Biol.Chem. 263, 4302-4308.

Skubitz APN, McCarthy JB, Charonis AS and Furcht LT (1988). Localization of three distinct heparin-binding domains of laminin by monoclonal antibodies. J.Biol.Chem. 263, 4861-4868

Charonis AS, Skubitz APN, Koliakos GG, Reger LA, Dege J, Vogel AM, Wohlhueter R and Furcht LT (1988). A novel synthetic peptide from the B1 chain of laminin with heparin-binding and cell adhesion-promoting activities. J.Cell Biol. 107, 1253-1260

Tsilibary EC, Koliakos GG, Charonis AS, Vogel AM, Reger LA and Furcht LT (1988). Heparin-type IV collagen interactions. Equilibrium binding and inhibition of type IV collagen self-assembly. J. Biol. Chem. 263, 19112-19118

Skubitz APN, McCarthy JB, Charonis AS and Furcht LT (1989). Novel synthetic peptides of laminin and fibronectin promote the adhesion of melanoma cells and heparin binding. Invasion and Metastasis 9, 89-101

Koliakos KK, Koliakos GG, Tsilibary EC, Furcht LT and Charonis AS (1989). Mapping of three major heparin binding sites on laminin and identification of a novel heparin binding site on the B1 chain. J.Biol. Chem. 265, 17971-17978

Charonis AS, Reger LA, Dege JE, Koliakos KK, Furcht LT, Wohlhueter RM and Tsilibary EC (1990). Laminin alterations after in vitro non-enzymatic glycosylation. Diabetes 39, 807-814

Tsilibary EC, Reger LA, Vogel AM, Koliakos GG, Anderson SS, Charonis AS, Allegre JN and Furcht LT (1990). Identification of a multifunctional, cell binding peptide sequence from the a1(NC1) of type IV collagen. J.Cell Biol. 111, 1583-1591

Brown DM, Charonis AS, Furcht LT, Klein DJ, Mauer SM, Steffes MW and Tsilibary EC (1991). The role of matrix components. An overview. Diabetes Care 14, 157-159

Koliakos GG, Tsilibary EC and Charonis AS (1991). A melanoma cell surface laminin binding protein with apparent Mr 90,000. Conn.Tissue Res. 26, 167-180

Campo E, Merino MJ, Tavassoli FA, Charonis AS, Stetler-Stevenson W and Liotta L (1992). Evaluation of basement membrane components and the 72kD type IV collagenase in serous tumors of the ovary. Am.J.Surg.Pathol. 16, 500-507

Fernandez PL, Merino MJ, Nogales FF, Charonis AS, Stetler-Stevenson W and Liotta L (1992). Immunohistochemical profile of basement membrane proteins and the 72 kD type IV collagenase in the implantation placental site. Lab.Invest. 66, 572-579

Haitoglou CS, Tsilibary EC, Brownlee M and Charonis AS (1992). Altered cellular interactions between endothelial cells and nonenzymatically glycosylated laminin /type IV collagen. J.Biol.Chem. 267, 12404-12407

Charonis AS and Tsilibary EC (1992). Structural and functional changes of laminin and type IV collagen following nonenzymatic glycation. Diabetes 41, 49-51

Campo E, Perez M, Charonis AS, Axiotis CA and Merino MJ (1992). Patterns of basement membrane laminin distribution in nonneoplastic and neoplastic thyroid tissue. Modern Pathol. 5, 540-546

Anderson SS, Tsilibary EC and Charonis AS (1993). Nonenzymatic glycosylation induced modifications of intact tubular basement membrane. J.Clinical Invest. 92, 3045-3052

Kalfa TA, Thull JD, Butkowski RJ and Charonis AS (1994). Tubulointerstitial Nephritis (TIN) antigen interacts with laminin and type IV collagen and promotes cell adhesion. J.Biol.Chem. 269, 1654-1659

Hasegawa G, Hunter AJ and Charonis AS (1995). Matrix nonenzymatic glycosylation leads to altered cellular phenotype and intracellular tyrosine phosphorylation. J.Biol. Chem. 270, 3278-3283

Nelson T, McIvor S, Charonis AS and Butkowski RJ (1995). Identification and sequencing of a full length cDNA clone coding for tubulointerstitial nephritis (TIN) antigen, a novel basement membrane macromolecule. J.Biol.Chem. 270, 16265-16270

Tsopanoglou N, Tsilibary EC and Charonis AS (1995). Putrescine, a novel inhibitor of glycosylation-induced crosslinks. Microcirculation 2, 283-287

Chen Y, Krishnamurti U, Wayner E, Michael A and Charonis AS (1996). Receptors in proximal tubule epithelial cells for tubulointerstitial nephritis antigen (TIN-ag). Kidney Internat. 49, 153-157

Kumar A, Ota K, Wada J, Wallner E, Charonis AS, Carone F and Kanwar YS (1997). Developmental regulation and partial-length cloning of tubulointerstitial nephritis antigen of murine metanephros Kidney Internat. 52, 620-627

Nelson TR, Michael AF, and Charonis AS (1997). Detection of tubulointerstitial nephritis antigen in the Lewis Rat Connect.Tiss. Res. 36, 223-229.

Nelson TR, Michael AF, Butkowski RJ and Charonis AS(1997). Expression of tubulointerstitial nephritis antigen (TIN-ag) during kidney development Connect. Tiss. Res. 37, 53-60

Ivanyi B, Haszon I, Endreffy P, Szenohradszky P, Petri IB, Kalmar T, Butkowski RJ, Charonis AS, and Turi S (1998). Childhood membranous nephropathy, circulating antibodies to the 58-kD TIN antigen and anti-tubular basement membrane nephritis: a follow-up during 11 years. Amer. J. Kidney Dis. 32, 1068-74.

Zhou B, Nelson TR, Kashtan C, Gleason B, Vlassi M, Michael AF and Charonis AS (2000). Identification of two alterantively spliced forms of human tubulointerstitial nephritis antigen (TIN-ag). Journal of the American Society of Nephrology 11, 658-668

Assimakopoulos SF, Scopa CD, Charonis A, Spiliopoulou I, Georgiou C, Nikolopoulou V, and Vagianos CE (2004). Experimental obstructive jaundice disrupts intestinal mucosal barrier by altering occluding expression: beneficial effect of bombesin neurotensin. J. Am. Coll. Surg. 198, 748-57

Assimakopoulos SF, Vagianos CE, Charonis A, Nikolopoulou VN, Scopa CD (2005). Intestinal failure in obstructive jaundice. World J. Gastr. 11, 3806-3807

Charonis AS, Sideraki V, Kaltezioti V, Alberti A, Vlahakos D, Wu K, Tsilibary EC (2005). Basement membrane peptides: functional considerations and biomedical applications in autoimmunity. Current Medicinal Chemistry, 12, 1495-1502

Assimakopoulos SF, Vagianos CE, Charonis AS, Alexandris IH, Spiliopoulou I, Thomopoulos KC, Nikolopoulou VN, Scopa CD . (2006). Experimental obstructive jaundice alters claudin-4 expression in the intestinal mucosa. Effectof bombesin and neurotensin. World J. Gastr. 12, 3410-3415

Kypreou K, Kavvadas P, Karamessinis P, Peroulis M, Alberti A, Sideras P, Psarras S, Capetanaki Y, Politis P, Charonis AS (2008). Altered expression of calreticulin during the development of fibrosis. Proteomics, 8, 2407-2419

Alberti A, Karamessinis P, Peroulis M, Kypreou K, Kavvadas P, Pagakis S, Politis P, Charonis AS (2009). Erp46 is reduced by high glucose and regulates insulin content in pancreatic beta cells. Am. J. Physiol. Endocrin. Metab. 297:E812-E821

Vlahou A, Charonis A, Benigni A (2009). Report on the first combined working group and management committee meeting of EuroKUP. J. Proteomics 71:682-684

Kotsovilis S, Tseleni-Balafouta S, Charonis A, Fourmousis I, Nikolidakis D, Vrotsos JA (2010). Syndecan-1 immunohistochemical expression in gingival tissues of chronic periodontitis patients correlated with various putative factors J. Periodont. Res. 45:520-531

Kavvadas P, Kypreou KP, Protopapadakis E, Prodromidi E, Sideras P, and Charonis AS (2010) Integrin-linked kinase (ILK) in pulmonary fibrosis Virchows Archiv. 457:563-575

Kaltezioti V, Kouroupi G, Oikonomaki M, Mantouvalou E, Stergiopoulos A, Charonis A, Rohrer H, Matsas R, and Politis P (2010). Prox1 Regulates the Notch1-Mediated Inhibition of Neurogenesis Plos Biol, 8(12) (e1000565)

Klein J, Kavvadas P, Prakoura N, Karagianni F, Schanstra JP, Bascands JL, Charonis AS (2011) Renal fibrosis: Insight from proteomics in animal models and human disease Proteomics, 11:805-815

Assimakopoulos SF, Tsamandas AC, Louvros E, Vagianos CE, Nikolopoulou VN, Thomopoulos KC, Charonis A, Scopa CD (2011). Intestinal epithelial cell proliferation, apoptosis and expression of Tight Junction proteins in patients with obstructive jaundice European Journal of Clinical Investigation, 41:117-125

Charonis A, Luider T, Baumann M, Schanstra JP (2011) Viewpoint: is the time ripe for kidney tissue proteomics? Proteomics: Clinical Applications, 5:215-221

Gerolymos M, Karagianni F, Papasotiriou M, Kalliakmani P, Goumenos D, Charonis A (2011). The expression of Transgelin in human glomerulonephritis of various etiology. Nephron, Clin. Pract. 119:74-82

Klein J, Jupp S, Moulos P, Fernandez M, Buffin-Meyer B, Chayaa R, Charonis A, Bascands JL, Stevens R, Schanstra JP (2012). The KUPKB: a novel web application to access multi-omics data on kidney disease. FASEB J.  26:2145-2153

Mischak H, Ioannidis J, Argiles A , Attwood T, Bongcam-Rudloff E, Broenstrup M, Charonis A, Chrousos G, Delles C, Dominiczak A, Dylag T, Ehrich J, Egido J, Findeisen P, Jankowski J, Johnson R, Julien B, Lankisch T, Leung H, Maahs D,  Magni F, Manns M, Manolis E, Mayer G, Navis G, Novak J, Ortiz A, Persson F, Karlheinz P, Riese H, Rossing P, Sattar N, Spasovski G, Thongboonkerd V, Vanholder R, Schanstra JP, Vlahou A.   Implementation of proteomic biomarkers: making it work.. Eur. J. Clin. Invest. (2012). doi: 10.1111/j. 1365-2362

Verouti SN, Tsilibary EC, Fragopoulou E, Iatrou C, Demopoulos CA, Charonis AS, Charonis SA, Drossopoulou GI.  Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes.  Nephron Exp Nephrol. 2012;122(1-2):36-50

Karagianni F, Prakoura N, Kaltsa G, Politis P, Arvaniti E, Kaltezioti V, Psarras S, Pagakis S, Katsimboulas M, Abed A, Chatziantoniou C, Charonis A.
Transgelin Up-Regulation in Obstructive Nephropathy.  PLoS One. 2013 Jun 26;8(6):e66887. Print 2013.

Assimakopoulos SF, Charonis AS.  Uncovering the molecular events associated with increased intestinal permeability in liver cirrhosis: the pivotal role of enterocyte tight junctions and future perspectives.  J Hepatol. 2013 Nov;59(5):1144-6

Prakoura N, Politis PK, Ihara Y, Michalak M, Charonis AS.  Epithelial calreticulin up-regulation promotes profibrotic responses and tubulointerstitial fibrosis development.   Am J Pathol. 2013 Nov;183(5):1474-87